ASCO21 Supplement | KCJ

KCJ Supplement - ASCO21 Special

ASCO21 Session

ASCO21 - RECOMMENDED ABSTRACTS IN KIDNEY CANCER

Robert A. Figlin, MD

Abstract
These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer............Show full content
ASCO21 MEETING REPORT

Practice Changing Results in RCC come from ASCO21

Marc R. Matrana, Erin Pierce, Erica Doubleday

Abstract
For the second year in a row, the annual meeting of the American Society of Clinical Oncology (ASCO) was held virtually due to the ongoing COVID-19 pandemic. Nonetheless, the meeting was hailed as a great success and brought much practice changing data in the field of genitourinary medical oncology, including kidney cancer..........Show full content
YOUNG ONCOLOGISTS CORNER

ASCO21 – Kidney Cancer Highlights

Jeffrey Graham, MD, MPH, FRCPC

Abstract
With the virtual ASCO21 meeting behind us, we can now pause and reflect on the data presented. This year’s program contained a number of exciting abstracts in the kidney cancer space, including potentially practice changing results in the adjuvant setting. In this article, I will highlight some of the most interesting abstracts related to kidney cancer/renal cell carcinoma, including those presented in the poster, oral, and plenary sessions ...Show full content
YOUNG ONCOLOGISTS CORNER

ASCO21 – Key Updates for Kidney Cancer Patients

Aberrant hypoxia signaling orchestrates metabolic reprogramming in clear cell renal cell carcinoma to support glycogen and lipid accumulation.

Neil Shah MD

Abstract
Over the last decade, novel immunotherapies and targeted therapies have revolutionized the kidney cancer treatment landscape. ASCO Annual Meeting, 2021, was yet another success against this battle, and in this commentary, we will focus on a few critical abstracts presented at the meeting pertinent to kidney cancer........Show full content
ASCO21- Nirmish Singla, MD

Nirmish Singla, MD

Novel Strategies in Locally Advanced Kidney Cancer – Highlights from KEYNOTE-564....Show full content
KCJ EDITOR’S MEMO

Robert A. Figlin MD

ASCO21 Kidney Cancer Roundup
The COVID-19 pandemic has exposed fundamental disparities in the provision of health care across our nation and exacerbated the differences in health outcomes associated with race, socioeconomic and other demographic factors. A silver lining however is that pandemic precarity has inspired tremendous scientific collaboration among clinicians, researchers, and key opinion leaders.....Show full content

Tweets by KidneyCancerJ

KCJ

KCJ

Vol 19, Issue 1
JUNE 2021

Table of content